Clinical trials sponsored by University Hospital, Geneva

Phase breakdown

Conditions studied

Recruiting trials led by University Hospital, Geneva

• Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure
  NCT06207383 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years and older · Sex: All (male and female) · 36 locations
• Breathlessness Patterns in Patients With Cancer, COPD and Heart Failure: an fMRI Feasibility Study
  NCT07319039 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Hypnosis on Breathlessness Mastery in Patients With Persistent Dyspnea
  NCT07173348 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Incremental Diagnostic Value of Tau-PET With [18F]RO948 vs Amyloid-PET in Patients With Cognitive Impairment
  NCT06618872 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 85 Years · Sex: All (male and female) · 2 locations
• Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors
  NCT07506356 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Neo-adjuvant Pembrolizumab and Radiotherapy in Localised MSS Rectal Cancer
  NCT04109755 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Neural Correlates of Motor and Psychiatric Fluctuations in Parkinson's Disease
  NCT07404241 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer
  NCT03294889 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 85 Years · Sex: Male · 1 location
• Patient-derived Organoids of Lung Cancer to Test Drug Response
  NCT03979170 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Impact of a Novel GnRH Antagonist With Add-back Therapy for Treatment of Uterine Fibroids and Endometriosis on Hemostasis Parameters
  NCT07173127 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Time-Restricted Eating in Menopause and HOrmone-sensitive Breast Cancers (TREMHO)
  NCT06855784 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 60 Years · Sex: Female · 1 location

Common questions

How many trials is University Hospital, Geneva recruiting for?

University Hospital, Geneva is the lead sponsor of 11 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.